Minirin (Desmopressin)

Desmopressin is used to manage disorders related to antidiuretic hormone deficiency or bleeding abnormalities.

• Central diabetes insipidus: reduces excessive urine output by increasing renal water reabsorption.
• Nocturnal enuresis: decreases nighttime bedwetting episodes by concentrating urine.
• Von Willebrand disease and mild hemophilia A: promotes release of clotting factors to control bleeding.

• Desmopressin is a synthetic analogue of vasopressin that selectively binds to V2 receptors on the basolateral membrane of renal collecting‑duct cells. Activation of V2 receptors stimulates adenylate cyclase, raising intracellular cAMP, which promotes insertion of aquaporin‑2 water channels into the apical membrane, enhancing water reabsorption and reducing urine volume.

Desmopressin may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Headache: mild to moderate intensity.
• Nausea: occasional, transient.
• Facial flushing: brief redness of skin.
• Nasal congestion: mild blockage.
• Mild hyponatremia: low sodium without severe symptoms.
• Abdominal discomfort: occasional cramps.

Serious or Rare Side Effects

• Severe hyponatremia: can lead to seizures or coma.
• Water intoxication: excessive fluid retention causing edema.
• Allergic reactions: rash, itching, or swelling.
• Hypertensive crisis: rare elevation of blood pressure.
• Thrombotic events: very rare clot formation.
• Pulmonary edema: fluid accumulation in lungs.

Before prescribing Desmopressin, clinicians should evaluate patient‑specific risk factors and monitor relevant parameters.

• Assess fluid balance: ensure adequate hydration status.
• Monitor serum sodium: check levels regularly, especially in the first weeks.
• Avoid concomitant antidiuretic agents: reduce risk of severe hyponatremia.
• Use caution in elderly: increased susceptibility to fluid shifts.
• Adjust dose in renal impairment: reduced clearance may require lower dosing.
• Store at below 25°C: keep in the original pack, protect from moisture.

Desmopressin can interact with several drug classes, altering its safety or efficacy.

Major Interactions (Avoid)

• Other antidiuretic agents (e.g., carbamazepine, chlorpropamide): risk of profound hyponatremia.
• MAO inhibitors: may potentiate antidiuretic effect and hyponatremia.
• Vasopressin analogues: additive water‑retaining effects.

Moderate Interactions (Monitor Closely)

• NSAIDs: can enhance renal water reabsorption.
• Loop diuretics: may diminish Desmopressin efficacy.
• SSRIs and SNRIs: increase risk of hyponatremia, especially in the elderly.